globalchange

Search Results

Help

Item hits: (Results 1-2 of 2)

Filters            
Items/Page:    Sort:
Efficacy and safety of chiglitazar, a novel peroxisome proliferator-activated receptor pan-agonist, in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, phase 3 trial (CMAP) [期刊论文]
Science Bulletin, 2021-01-01, 66 (15
Ji L.;  Song W.;  Fang H.;  Li W.;  Geng J.;  Wang Y.;  Guo L.;  Cai H.;  Yang T.;  Li H.;  Yang G.;  Li Q.;  Liu K.;  Li S.;  Liu Y.;  Shi F.;  Li X.;  Gao X.;  Tian H.;  Ji Q.;  Su Q.;  Zhou Z.;  Wang W.;  Zhou Z.;  Li X.;  Xu Y.;  Ning Z.;  Cao H.;  Pan D.;  Yao H.;  Lu X.;  Jia W.
View/Download:28/0
 
Single-cell RNA-seq unveils critical regulators of human FOXP3+ regulatory T cell stability [期刊论文]
Science Bulletin, 2020-01-01, 65 (13
Yi G.;  Zhao Y.;  Xie F.;  Zhu F.;  Wan Z.;  Wang J.;  Wang X.;  Gao K.;  Cao L.;  Li X.;  Chen C.;  Kuang Y.;  Qiu X.;  Yang H.;  Wang J.;  Su B.;  Chen L.;  Zhang W.;  Hou Y.;  Xu X.;  He Y.;  Tsun A.;  Liu X.;  Li B.
View/Download:12/0
 

1